DARAIO, FILOMENA
DARAIO, FILOMENA
SCIENZE CLINICHE E BIOLOGICHE
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4
2015-01-01 Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G
Consistency Of RQPCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View
2013-01-01 Rege Cambrin, G; Fava, C; Gottardi, E; Daraio, F; Giugliano, E; Crasto, F; Lorenzatti, R; Volpengo, A; Di Gioacchino, B; Saglio, G
DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION
2016-01-01 Fava, C; Varotto, M; Berchialla, P; Gottardi, E; Daraio, F; Lorenzatti, R; Giugliano, E; Barberio, D; Iurlo, A; Cattaneo, D; Orlandi, E; Chiara, E; Pregno, P; Nicolosi, M; Ferrero, D; Riera, L; Rege-Cambrin, G; Saglio, G
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS
2015-01-01 Fava, C; Rege-Cambrin, G; Dogliotti, I; Gottardi, E; Berchialla, P; Di Gioacchino, B; Crasto, F; Lorenzatti, R; Volpengo, A; Daraio, F; Fantino, C; Saglio, G
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA.
2015-01-01 C. Panuzzo, G. Volpe, E. Cibrario Rocchietti, C. Casnici, K. Crotta, S. Crivellaro, G. Carrà, F. Daraio, R. Lorenzatti, D. Torti, A. Morotti,O. Marelli, G. Saglio
One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment.
2012-01-01 Filomena Daraio; Davide Barberis; Francesca Crasto; Giovanna Rege-Cambrin; Cristina Olivo; Matteo Renzulli; Rosy Volpi; Roberta Lorenzatti; Carmen Fava; Enrico Gottardi; and Giuseppe Saglio.
STANDARD AND HIGH SENSITIVITY MOLECULAR ANALYSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS CANDIDATE TO DISCONTINUATION OF TYROSINE KINASE INHIBITORS
2014-01-01 Dogliotti, I; Fava, C; Gottardi, E; Daraio, F; Giugliano, E; Ulisciani, S; Saglio, G; Rege-Cambrin, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 | 2015 | Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G | |
| Consistency Of RQPCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View | 2013 | Rege Cambrin, G; Fava, C; Gottardi, E; Daraio, F; Giugliano, E; Crasto, F; Lorenzatti, R; Volpengo, A; Di Gioacchino, B; Saglio, G | |
| DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION | 2016 | Fava, C; Varotto, M; Berchialla, P; Gottardi, E; Daraio, F; Lorenzatti, R; Giugliano, E; Barberio, D; Iurlo, A; Cattaneo, D; Orlandi, E; Chiara, E; Pregno, P; Nicolosi, M; Ferrero, D; Riera, L; Rege-Cambrin, G; Saglio, G | |
| EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS | 2015 | Fava, C; Rege-Cambrin, G; Dogliotti, I; Gottardi, E; Berchialla, P; Di Gioacchino, B; Crasto, F; Lorenzatti, R; Volpengo, A; Daraio, F; Fantino, C; Saglio, G | |
| NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. | 2015 | C. Panuzzo, G. Volpe, E. Cibrario Rocchietti, C. Casnici, K. Crotta, S. Crivellaro, G. Carrà, F. Daraio, R. Lorenzatti, D. Torti, A. Morotti,O. Marelli, G. Saglio | |
| One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment. | 2012 | Filomena Daraio; Davide Barberis; Francesca Crasto; Giovanna Rege-Cambrin; Cristina Olivo; Matteo Renzulli; Rosy Volpi; Roberta Lorenzatti; Carmen Fava; Enrico Gottardi; and Giuseppe Saglio. | |
| STANDARD AND HIGH SENSITIVITY MOLECULAR ANALYSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS CANDIDATE TO DISCONTINUATION OF TYROSINE KINASE INHIBITORS | 2014 | Dogliotti, I; Fava, C; Gottardi, E; Daraio, F; Giugliano, E; Ulisciani, S; Saglio, G; Rege-Cambrin, G |